Mon, 15 Jul 2019 15:21:41: Novartis offloads lagging endocrine drugs to Recordati for $390M

Mon, 15 Jul 2019 14:42:42: AstraZeneca's Farxiga follows rival Zynquista to FDA rejection in Type 1 diabetes

Mon, 15 Jul 2019 14:27:29: Indoco caught in maelstrom of FDA concerns as plant hit with warning letter

Mon, 15 Jul 2019 14:03:11: AbbVie's rising immunology star Skyrizi scores nod from England's cost watchdog

Mon, 15 Jul 2019 14:01:45: GSK's Zejula racks up first-line maintenance win in ovarian cancer, even in non-BRCA patients

Sun, 14 Jul 2019 18:18:18: Publicis debuts HealthFront with industry-specific take on Upfront and NewFront media events

Fri, 12 Jul 2019 18:09:01: Johnson & Johnson faces criminal probe over talc statements: report

Fri, 12 Jul 2019 15:06:50: Emgality maker Lilly courts payers with new migraine ER data

Fri, 12 Jul 2019 14:37:33: ICER deems unapproved Aimmune, DBV peanut allergy drugs unaffordable, sparking backlash

Fri, 12 Jul 2019 14:21:05: With test, Merck takes temperature-controlled drug delivery by drone from remote idea to remote locations

Fri, 12 Jul 2019 14:05:34: Thanks to patent win, Amgen ready to kick PCSK9 rivals Sanofi, Regeneron off the market in Germany

Fri, 12 Jul 2019 11:58:22: FiercePharmaAsia—J&J-Hanmi obesity breakup; BI-Yuhan NASH tie-up; GSK sites in China, Singapore

Thu, 11 Jul 2019 22:42:36: Gilead snags Lilly exec Shaw for Kite CEO position

Thu, 11 Jul 2019 18:50:36: Sanofi, Regeneron turn to photos, data plots to set Libtayo apart from I-O rivals

Thu, 11 Jul 2019 14:33:21: Alnylam recruits former Shire exec to replace departing CFO Soni

Thu, 11 Jul 2019 14:21:59: Indivior's former parent ponies up a whopping $1.4B to settle Suboxone marketing probe

Thu, 11 Jul 2019 14:20:44: Biohaven, sporting new data, moves closer to CGRP finish line—and maybe M&A

Thu, 11 Jul 2019 13:53:03: Lilly Bio-Medicines chief Christi Shaw steps aside, leaving key launches behind

Thu, 11 Jul 2019 13:21:41: Sterile drug maker Nexus launches $250M U.S. manufacturing project

Thu, 11 Jul 2019 12:47:42: Sorry, pharma: White House pulls industry's favored rebate proposal

Wed, 10 Jul 2019 14:48:43: Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void

Wed, 10 Jul 2019 14:25:13: The hits keep coming: Apotex loses 31 drug approvals after FDA cites plants for 'inadequate' controls

Wed, 10 Jul 2019 14:22:41: GSK touts new Dovato switching data. Is it enough to shake Gilead's HIV lead?

Wed, 10 Jul 2019 14:05:14: Warning letter faults Akorn management for plant failures

Wed, 10 Jul 2019 13:43:00: FDA promises 'elevated' new drug approvals, but warns of potential pitfalls: report